Mechanisms of TNFα regulation in uveitis: Focus on RNA-binding proteins

Progress in Retinal and Eye Research

Volumn 29, Issue 6, 2010, Pages 610-621

  Khera, Tarnjit K ^a   Dick, Andrew D ^a   Nicholson, Lindsay B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIGEN; ANTIINFLAMMATORY AGENT; APRATASTAT; BM 561392; BMS 561392; ETANERCEPT; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X RELATED PROTEIN 1; GW 333; HUMAN ANTIGEN R; INFLIXIMAB; INTERLEUKIN 10; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN P55; PROTEIN P55 TUMOR NECROSIS FACTOR RECEPTOR IMMUNOGLOBULIN G1 FUSION PROTEIN; REACTIVE OXYGEN METABOLITE; RNA BINDING PROTEIN; SYNAPSIN I; T LYMPHOCYTE INTRACELLULAR ANTIGEN 1; T LYMPHOCYTE INTRACELLULAR ANTIGEN 1 RELATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRISTETRAPROLIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; WNT PROTEIN INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; AUTOIMMUNITY; CELL MEMBRANE; CELL MIGRATION; CHRONIC INFLAMMATION; CLINICAL TRIAL; DIABETIC RETINOPATHY; DISEASE MODEL; DRUG MECHANISM; DRUG TARGETING; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME DEGRADATION; EXPERIMENTAL STUDY; EYE INFLAMMATION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION; INFECTION RISK; KNOCKOUT MOUSE; LISTERIOSIS; LYMPHOCYTE FUNCTION; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MOLECULAR INTERACTION; MYCOBACTERIOSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN SYNTHESIS REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; T LYMPHOCYTE; TISSUE INJURY; TRANSGENIC MOUSE; TRANSLATION INITIATION; TRANSLATION REGULATION; TREATMENT RESPONSE; UVEITIS; WILD TYPE;

EID: 78650192122     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2010.08.003     Document Type: Review

References (206)

1. Abraham S.M., Lawrence T., Kleiman A., Warden P., Medghalchi M., Tuckermann J., Saklatvala J., Clark A.R. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. The Journal of Experimental Medicine 2006, 203:1883-1889.
2. Ahn J.K., Yu H.G., Chung H., Park Y.G. Intraocular cytokine Environment in active Behcet uveitis. American Journal of Ophthalmology 2006, 142:429-434. e421.
3. Alexopoulou L., Kranidioti K., Xanthoulea S., Denis M., Kotanidou A., Douni E., Blackshear P.J., Kontoyiannis D.L., Kollias G. Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. European Journal of Immunology 2006, 36:2768-2780.
4. Ali T.K., El-Remessy A.B. Diabetic retinopathy: current management and experimental therapeutic targets. Pharmacotherapy 2009, 29:182-192.
5. Amadi-Obi A., Yu C.-R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., Gery I., Lee Y.S., Egwuagu C.E. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Natural Medicine 2007, 13:711-718.
6. Anderson P., Kedersha N. RNA granules. The Journal of Cell Biology 2006, 172:803-808.
7. Antic D., Keene J.D. Embryonic lethal abnormal visual RNA-Binding proteins involved in growth, differentiation, and posttranscriptional gene expression. The American Journal of Human Genetics 1997, 61:273-278.
8. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P.Y. TNF[alpha] promotes proliferation of oligodendrocyte progenitors and remyelination. Nature Neuroscience 2001, 4:1116-1122.
9. Atasoy U., Watson J., Patel D., Keene J.D. ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. Journal of Cell Science 1998, 111:3145-3156.
10. Aznarez I., Barash Y., Shai O., He D., Zielenski J., Tsui L.-C., Parkinson J., Frey B.J., Rommens J.M., Blencowe B.J. A systematic analysis of intronic sequences downstream of 5′ splice sites reveals a widespread role for U-rich motifs and TIA1/TIAL1 proteins in alternative splicing regulation. Genome Research 2008, 18:1247-1258.
11. Bakheet T., Frevel M., Williams B.R.G., Greer W., Khabar K.S.A. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Research 2001, 29:246-254.
12. Bartel D.P. MicroRNAs: Genomics. Biogenesis, Mechanism, and Function 2004, 116:281-297.
13. Beck A.R., Medley Q.G., O'Brien S., Anderson P., Streuli M. Structure, tissue distribution and genomic organization of the murine RRM-type RNA binding proteins TIA-1 and TIAR. Nucleic Acids Research 1996, 24:3829-3835.
14. Beutler B., Krochin N., Milsark I.W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986, 232:977-980.
15. Beutler B., Milsark I.W., Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985, 229:869-871.
16. Biragyn A., Nedospasov S.A. Lipopolysaccharide-induced expression of TNF-alpha gene in the macrophage cell line ANA-1 is regulated at the level of transcription processivity. The Journal of Immunology 1995, 155:674-683.
17. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997, 385:729-733.
18. Blackshear P.J. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochemical Society Transactions 2002, 30:945-952.
19. Bogdan C., Paik J., Vodovotz Y., Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. Journal of Biological Chemistry 1992, 267:23301-23308.
20. Boschert V., Krippner-Heidenreich A., Branschädel M., Tepperink J., Aird A., Scheurich P. Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2. Cellular Signalling 2010, 22:1088-1096.
21. Bradley J.R. TNF-mediated inflammatory disease. The Journal of Pathology 2008, 214:149-160.
22. Broderick C., Hoek R.M., Forrester J.V., Liversidge J., Sedgwick J.D., Dick A.D. Constitutive retinal CD200 expression regulates resident microglia and activation State of inflammatory cells during experimental autoimmune uveoretinitis. American Journal of Pathology 2002, 161:1669-1677.
23. Brook M., Sully G., Clark A.R., Saklatvala J. Regulation of tumour necrosis factor-alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Letters 2000, 483:57-61.
24. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D., et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 2001, 107:477-487.
25. Buxadé M., Parra J.L., Rousseau S., Shpiro N., Marquez R., Morrice N., Bain J., Espel E., Proud C.G. The Mnks are novel components in the control of TNF-alpha biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 2005, 23:177-189.
26. Calder C.J., Nicholson L.B., Dick A.D. A selective role for the TNF p55 receptor in autocrine signaling following IFN-gamma stimulation in experimental autoimmune uveoretinitis. The Journal of Immunology 2005, 175:6286-6293.
27. Calder V.L., Shaer B., Muhaya M., McLauchlan M., Pearson R.V., Jolly G., Towler H.M.A., Lightman S. Increased CD4+ expression and decreased IL-10 in the anterior chamber in Idiopathic uveitis. Investigative Ophthalmology & Visual Science 1999, 40:2019-2024.
28. Caput D., Beutler B., Hartog K., Thayer R., Brown-Shimer S., Cerami A. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proceedings of the National Academy of Sciences of the United States of America 1986, 83:1670-1674.
29. Carballo E., Blackshear P.J. Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome. Blood 2001, 98:2389-2395.
30. Carballo E., Lai W.S., Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998, 281:1001-1005.
31. Caspi R., Silver P., Cua D., Chen Z., Chan C.-C., Luger D. IL-23 and IL-17 in pathogenesis of experimental ocular autoimmunity: requirement for IL-23 may extend beyond its role in sustaining the IL-17 effector response. The Journal of Immunology 2007, 178. S222-d-.
32. Caspi R.R., Roberge F.G., McAllister C.G., el-Saied M., Kuwabara T., Gery I., Hanna E., Nussenblatt R.B. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. The Journal of Immunology 1986, 136:928-933.
33. Caspi R.R., Silver P.B., Chan C.C., Sun B., Agarwal R.K., Wells J., Oddo S., Fujino Y., Najafian F., Wilder R.L. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. The Journal of Immunology 1996, 157:2668-2675.
34. Caudy A.A., Myers M., Hannon G.J., Hammond S.M. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes & Development 2002, 16:2491-2496.
35. Ceman S., O'Donnell W.T., Reed M., Patton S., Pohl J., Warren S.T. Phosphorylation influences the translation state of FMRP-associated polyribosomes. Human Molecular Genetics 2003, 12:3295-3305.
36. Chaussabel D., Semnani R.T., McDowell M.A., Sacks D., Sher A., Nutman T.B. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 2003, 102:672-681.
37. Chen C.-Y.A., Shyu A.-B. AU-rich elements: characterization and importance in mRNA degradation. Trends in Biochemical Sciences 1995, 20:465-470.
38. Chen Y., Hu Y., Zhou T., Zhou K.K., Mott R., Wu M., Boulton M., Lyons T.J., Gao G., Ma J.-X. Activation of the wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. American Journal of Pathology 2009, 175:2676-2685.
39. Chrestensen C.A., Schroeder M.J., Shabanowitz J., Hunt D.F., Pelo J.W., Worthington M.T., Sturgill T.W. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. Journal of Biological Chemistry 2004, 279:10176-10184.
40. Clark A.R., Dean J.L.E., Saklatvala J. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Letters 2003, 546:37-44.
41. Cook M.C., Korner H., Sean Riminton D., Lemckert F.A., Hasbold J., Amesbury M., Hodgkin P.D., Cyster J.G., Sedgwick J.D., Basten A. Generation of Splenic follicular structure and B cell movement in tumor necrosis factor-alpha deficient mice. The Journal of Experimental Medicine 1998, 188:1503-1510.
42. Cope A.P., Liblau R.S., Yang X.-D., Congia M., Laudanna C., Schreiber R.D., Probert L., Kollias G., McDevitt H.O. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. The Journal of Experimental Medicine 1997, 185:1573-1584.
43. Copland D.A., Calder C.J., Raveney B.J.E., Nicholson L.B., Phillips J., Cherwinski H., Jenmalm M., Sedgwick J.D., Dick A.D. Monoclonal antibody-mediated CD200 receptor signaling Suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. American Journal of Pathology 2007, 171:580-598.
44. Czermak B.J., Sarma V., Bless N.M., Schmal H., Friedl H.P., Ward P.A. In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha. The Journal of Immunology 1999, 162:2321-2325.
45. Dai Y., Datta S., Novotny M., Hamilton T.A. TGF-beta inhibits LPS-induced chemokine mRNA stabilization. Blood 2003, 102:1178-1185.
46. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 2001, 107:489-499.
47. de Wit D., Lightman S. Emerging approaches to the treatment of uveitis: patents of 2000-2004. Expert Opinion on Therapeutic Patents 2005, 15:861-874.
48. Dean J.L.E., Wait R., Mahtani K.R., Sully G., Clark A.R., Saklatvala J. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-Stabilizing factor HuR. Molecular and Cellular Biology 2001, 21:721-730.
49. Del Gatto-Konczak F., Bourgeois C.F., Le Guiner C., Kister L., Gesnel M.-C., Stevenin J., Breathnach R. The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5′ splice site. Molecular and Cellular Biology 2000, 20:6287-6299.
50. Dember L.M., Kim N.D., Liu K.-Q., Anderson P. Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding Specificities. Journal of Biological Chemistry 1996, 271:2783-2788.
51. Dick A.D., Duncan L., Hale G., Waldmann H., Isaacs J. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. Journal of Autoimmunity 1998, 11:255-264.
52. Dick A.D., Forrester J.V., Liversidge J., Cope A.P. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). Progress in Retinal and Eye Research 2004, 23:617-637.
53. Dick A.D., McMenamin P.G., Körner H., Scallon B.J., Ghrayeb J., Forrester J.V., Sedgwick J.D. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. European Journal of Immunology 1996, 26:1018-1025.
54. DuBois R.N., McLane M.W., Ryder K., Lau L.F., Nathans D. A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence. Journal of Biological Chemistry 1990, 265:19185-19191.
55. Eberhart D.E., Malter H.E., Feng Y., Warren S.T. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Human Molecular Genetics 1996, 5:1083-1091.
56. Engels B., van 't Padje S., Blonden L., Severijnen L.-a., Oostra B.A., Willemsen R. Characterization of Fxr1 in Danio rerio; a simple vertebrate model to study costamere development. Journal of Experimental Biology 2004, 207:3329-3338.
57. Eugster H.-P., Frei K., Bachmann R., Bluethmann H., Lassmann H., Fontana A. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. European Journal of Immunology 1999, 29:626-632.
58. Fan X.C., Steitz J.A. HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:15293-15298.
59. Fan X.C., Steitz J.A. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. The EMBO Journal 1998, 17:3448-3460.
60. Feduchi E., Alonso M.A., Carrasco L. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. Journal of Virology 1989, 63:1354-1359.
61. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nature Reviews Immunology 2002, 2:364-371.
62. Fields M., Zheng M., Zhang M., Atherton S.S. Tumor necrosis factor alpha and macrophages in the brain of herpes simplex virus type 1-alpha infected BALB/c mice. Journal of Neurovirology 2006, 12:443-455.
63. Förch P., Puig O., Kedersha N., Martínez C., Granneman S., Séraphin B., Anderson P., Valcárcel J. The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Molecular Cell 2000, 6:1089-1098.
64. Forch P., Puig O., Martinez C., Seraphin B., Valcarcel J. The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5′ splice sites. The EMBO Journal 2002, 21:6882-6892.
65. Forrester J.V., Huitinga I., Lumsden L., Dijkstra C.D. Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats. Current Eye Research 1998, 17:426-437.
66. Garnon J., Lachance C., Di Marco S., Hel Z., Marion D., Ruiz M.C., Newkirk M.M., Khandjian E.W., Radzioch D. Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level. Journal of Biological Chemistry 2005, 280:5750-5763.
67. Gilks N., Kedersha N., Ayodele M., Shen L., Stoecklin G., Dember L.M., Anderson P. Stress granule assembly is mediated by prion-like aggregation of TIA-1. Molecular Biology of the Cell 2004, 15:5383-5398.
68. Good P.J. A conserved family of elav-like genes in vertebrates. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:4557-4561.
69. Greiner K., Murphy C.C., Willermain F., Duncan L., Plskova J., Hale G., Isaacs J.D., Forrester J.V., Dick A.D. Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation. Investigative Ophthalmology & Visual Science 2004, 45:170-176.
70. Grell M., Becke M.F., Wajant H., Männel N.D., Scheurich P. Tumor necrosis factor (TNF) receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. European Journal of Immunology 1998, 28:257-263.
71. Grell M., Douni E., Wajant H., Löhden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K., Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995, 83:793-802.
72. Gueydan C., Droogmans L., Chalon P., Huez G., Caput D., Kruys V. Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor-alpha mRNA. Journal of Biological Chemistry 1999, 274:2322-2326.
73. Gustavsson C., Agardh E., Bengtsson B., Agardh C.-D. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients. Journal of Diabetes and Its Complications 2008, 22:309-316.
74. Hammer M., Mages J., Dietrich H., Servatius A., Howells N., Cato A.C., Lang R. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. The Journal of Experimental Medicine 2006, 203:15-20.
75. Han J., Brown T., Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. The Journal of Experimental Medicine 1990, 171:465-475.
76. Han J., Huez G., Beutler B. Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. The Journal of Immunology 1991, 146:1843-1848.
77. Hao S., Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nature Immunology 2009, 10:281-288.
78. Harashima S.-i., Horiuchi T., Hatta N., Morita C., Higuchi M., Sawabe T., Tsukamoto H., Tahira T., Hayashi K., Fujita S., Niho Y. Outside-to-inside signal through the membrane TNF-alpha induces E-selectin (CD62E) expression on activated human CD4+ T cells. The Journal of Immunology 2001, 166:130-136.
79. He M.M., Smith A.S., Oslob J.D., Flanagan W.M., Braisted A.C., Whitty A., Cancilla M.T., Wang J., Lugovskoy A.A., Yoburn J.C., et al. Small-Molecule inhibition of TNF-alpha. Science 2005, 310:1022-1025.
80. He X., Semenov M., Tamai K., Zeng X. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 2004, 131:1663-1677.
81. Hehlgans T., Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005, 115:1-20.
82. Henness S., Johnson C.K., Ge Q., Armour C.L., Hughes M.J., Ammit A.J. IL-17A augments TNF-alpha induced IL-6 expression in airway smooth muscle by enhancing mRNA stability. The Journal of Allergy and Clinical Immunology 2004, 114:958-964.
83. Hieronymus H., Silver P.A. A systems view of mRNP biology. Genes & Development 2004, 18:2845-2860.
84. Hitti E., Iakovleva T., Brook M., Deppenmeier S., Gruber A.D., Radzioch D., Clark A.R., Blackshear P.J., Kotlyarov A., Gaestel M. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Molecular and Cellular Biology 2006, 26:2399-2407.
85. Holtmann H., Winzen R., Holland P., Eickemeier S., Hoffmann E., Wallach D., Malinin N.L., Cooper J.A., Resch K., Kracht M. Induction of Interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Molecular and Cellular Biology 1999, 19:6742-6753.
86. Imrie F.R., Dick A.D. Biologics in the treatment of uveitis. Current Opinion in Ophthalmology 2007, 18:481-486. 410.1097/ICU.1090b1013e3282f1003d1042.
87. Ishizuka A., Siomi M.C., Siomi H. A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes & Development 2002, 16:2497-2508.
88. Izquierdo J.M., Valcarcel J. Two isoforms of the T-cell intracellular antigen 1 (TIA-1) splicing factor display distinct splicing regulation activities. Journal of Biological Chemistry 2007, 282:19410-19417.
89. Jakymiw A., Pauley K.M., Li S., Ikeda K., Lian S., Eystathioy T., Satoh M., Fritzler M.J., Chan E.K.L. The role of GW/P-bodies in RNA processing and silencing. Journal of Cell Science 2007, 120:1317-1323.
90. Jasielska M., Semkova I., Shi X., Schmidt K., Karagiannis D., Kokkinou D., Mackiewicz J., Kociok N., Joussen A.M. Differential role of tumor necrosis factor (TNF)-alpha receptors in the development of choroidal neovascularization. Investigative Ophthalmology & Visual Science 2010, 51:3874-3883.
91. Jin P., Zarnescu D.C., Ceman S., Nakamoto M., Mowrey J., Jongens T.A., Nelson D.L., Moses K., Warren S.T. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nature Neuroscience 2004, 7:113-117.
92. Johnson B.A., Stehn J.R., Yaffe M.B., Blackwell T.K. Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms. Journal of Biological Chemistry 2002, 277:18029-18036.
93. Joussen A.M., Poulaki V., Le M.L., Koizumi K.A.N., Esser C., Janicki H., Schraermeyer U., Kociok N., Fauser S., Kirchhof B., et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2004, 18:1450-1452.
94. Kapranov P., Ozsolak F., Kim S.W., Foissac S., Lipson D., Hart C., Roels S., Borel C., Antonarakis S.E., Monaghan A.P., et al. New class of gene-termini-associated human RNAs suggests a novel RNA copying mechanism. Nature 2010, 466:642-646.
95. Kassiotis G., Pasparakis M., Kollias G., Probert L. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis. European Journal of Immunology 1999, 29:774-780.
96. Katsanou V., Papadaki O., Milatos S., Blackshear P.J., Anderson P., Kollias G., Kontoyiannis D.L. HuR as a negative posttranscriptional modulator in inflammation. Molecular Cell 2005, 19:777-789.
97. Kawakami A., Tian Q., Duan X., Streuli M., Schlossman S.F., Anderson P. Identification and functional characterization of a TIA-1-related nucleolysin. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:8681-8685.
98. Kawakami A., Tian Q., Streuli M., Poe M., Edelhoff S., Disteche C.M., Anderson P. Intron-exon organization and chromosomal localization of the human TIA- 1 gene. The Journal of Immunology 1994, 152:4937-4945.
99. Kaymakcalan Z., Sakorafas P., Bose S., Scesney S., Xiong L., Hanzatian D.K., Salfeld J., Sasso E.H. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clinical Immunology 2009, 131:308-316.
100. Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., Siegel J.N., Braun M.M. Tuberculosis associated with infliximab, a tumor necrosis factor-alpha-neutralizing agent. The New England Journal of Medicine 2001, 345:1098-1104.
101. Kedersha N., Anderson P. Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Biochemical Society Transactions 2002, 30:963-969.
102. Kedersha N.L., Gupta M., Li W., Miller I., Anderson P. RNA-binding proteins Tia-1 and Tiar link the phosphorylation of Eif-2alpha to the assembly of mammalian stress granules. The Journal of Cell Biology 1999, 147:1431-1442.
103. Kempen J.H., Daniel E., Dunn J.P., Foster C.S., Gangaputra S., Hanish A., Helzlsouer K.J., Jabs D.A., Kacmaz R.O., Levy-Clarke G.A., et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. British Medical Journal 2009, 339:b2480.
104. Kerr E.C., Raveney B.J.E., Copland D.A., Dick A.D., Nicholson L.B. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. Journal of Autoimmunity 2008, 31:354-361.
105. Khera T., Dick A., Nicholson L. Fragile X related protein FXR1 controls post-transcriptional suppression of LPS-induced TNFα by TGFβ1. FEBS Journal 2010, 277:2754-2765.
106. King P.H., Levine T.D., Fremeau R.T., Keene J.D. Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3′ UTR of mRNA encoding the Id transcriptional repressor. Journal of Neuroscience 1994, 14:1943-1952.
107. Kirchner S., Holler E., Haffner S., Andreesen R., Eissner G. Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes. Cytokine 2004, 28:67-74.
108. Kirkpatrick L.L., McIlwain K.A., Nelson D.L. Alternative splicing in the murine and human FXR1 genes. Genomics 1999, 59:193-202.
109. Kirkpatrick L.L., McIlwain K.A., Nelson D.L. Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. Genomics 2001, 78:169-177.
110. Kodukula P., Liu T., Rooijen N.V., Jager M.J., Hendricks R.L. Macrophage control of Herpes simplex virus type 1 replication in the peripheral nervous system. The Journal of Immunology 1999, 162:2895-2905.
111. Kontoyiannis D., Pasparakis M., Pizarro T.T., Cominelli F., Kollias G. Impaired On/Off regulation of TNF biosynthesis in mice lacking TNF AU-Rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999, 10:387-398.
112. Korner H., Riminton D.S., Strickland D.H., Lemckert F.A., Pollard J.D., Sedgwick J.D. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. The Journal of Experimental Medicine 1997, 186:1585-1590.
113. Kotlyarov A., Neininger A., Schubert C., Eckert R., Birchmeier C., Volk H.-D., Gaestel M. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nature Cell Biology 1999, 1:94-97.
114. Krippner-Heidenreich A., Tubing F., Bryde S., Willi S., Zimmermann G., Scheurich P. Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction. Journal of Biological Chemistry 2002, 277:44155-44163.
115. Lachance C., Thuraisingam T., Garnon J., Roter E., Radzoich D. Posttranscriptional gene expression regulation in CpG-activated macrophages depends on FXR1P RNA-binding protein. FEMS Immunology & Medical Microbiology 2007, 51:422-430.
116. Laggerbauer B., Ostareck D., Keidel E.-M., Ostareck-Lederer A., Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Human Molecular Genetics 2001, 10:329-338.
117. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Phillips R.S., Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilisationof tumour necrosis factor-alpha mRNA. Molecular and Cellular Biology 1999, 19:4311-4323.
118. Lasa M., Mahtani K.R., Finch A., Brewer G., Saklatvala J., Clark A.R. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Molecular and Cellular Biology 2000, 20:4265-4274.
119. Lenercept-MS-Study-Group TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999, 53:444-445.
120. Li Z., Zhang Y., Ku L., Wilkinson K.D., Warren S.T., Feng Y. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Research 2001, 29:2276-2283.
121. Lichtlen P.D., Lam T., Nork M., Streit T., Urech D.M. Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing efficacy of bevacizumab, adalimumab and ESBA105. Investigative Ophthalmology & Visual Science 2010, iovs.09-4890.
122. Ma W.-J., Cheng S., Campbell C., Wright A., Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed elav-like protein. Journal of Biological Chemistry 1996, 271:8144-8151.
123. Mackay F., Bourdon P.R., Griffiths D.A., Lawton P., Zafari M., Sizing I.D., Miatkowski K., Ngam-ek A., Benjamin C.D., Hession C., et al. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes. The Journal of Immunology 1997, 159:3299-3310.
124. Mahtani K.R., Brook M., Dean J.L.E., Sully G., Saklatvala J., Clark A.R. Mitogen-Activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Molecular and Cellular Biology 2001, 21:6461-6469.
125. Mazroui R., Huot M.-E., Tremblay S., Filion C., Labelle Y., Khandjian E.W. Trapping of messenger RNA by Fragile X mental retardation protein into cytoplasmic granules induces translation repression. Human Molecular Genetics 2002, 11:3007-3017.
126. McAlinden A., Liang L., Mukudai Y., Imamura T., Sandell L.J. Nuclear protein TIA-1 regulates COL2A1 alternative splicing and interacts with precursor mRNA and genomic DNA. Journal of Biological Chemistry 2007, 282:24444-24454.
127. McMullen M.R., Cocuzzi E., Hatzoglou M., Nagy L.E. Chronic ethanol exposure increases the binding of HuR to the TNF-alpha-untranslated region in macrophages. Journal of Biological Chemistry 2003, 278:38333-38341.
128. Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., and Tuschl, T., 2004. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Molecular Cell 15, 185-197.
129. Minagawa H., Hashimoto K., Yanagi Y. Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections. Journal of General Virology 2004, 85:343-347.
130. Ming X.-F., Stoecklin G., Lu M., Looser R., Moroni C. Parallel and independent regulation of Interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Molecular and Cellular Biology 2001, 21:5778-5789.
131. Moreira A.L., Sampaio E.P., Zmuidzinas A., Frindt P., Smith K.A., Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. Journal of Experimental Medicine 1993, 177:1675-1680.
132. Moss M.L., Sklair-Tavron L., Nudelman R. Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis. Nature Clinical Practice Rheumatology 2008, 4:300-309.
133. Murphy C.C., Duncan L., Forrester J.V., Dick A.D. Systemic CD4+ T cell phenotype and activation status in intermediate uveitis. British Journal of Ophthalmology 2004, 88:412-416.
134. Murphy C.C., Greiner K., Plskova J., Duncan L., Frost A., Isaacs J.D., Rebello P., Waldmann H., Hale G., Forrester J.V., Dick A.D. Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis. Archives of Ophthalmology 2004, 122:845-851.
135. Mysliwiec M., Balcerska A., Zorena K., Mysliwska J., Lipowski P., Raczynska K. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy. Diabetes Research and Clinical Practice 2008, 79:141-146.
136. Nau G.J., Richmond J.F.L., Schlesinger A., Jennings E.G., Lander E.S., Young R.A. Human macrophage activation programs induced by bacterial pathogens. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:1503-1508.
137. Neininger A., Kontoyiannis D., Kotlyarov A., Winzen R., Eckert R., Volk H.-D., Holtmann H., Kollias G., Gaestel M. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and Interleukin-6 independently at different post-transcriptional levels. Journal of Biological Chemistry 2002, 277:3065-3068.
138. Niesman M.R., Ni M., Bloom J.N. Liposome-encapsulated clodronate retards the development of experimental autoimmune uveitis. Journal of Liposome Research 1998, 8:367-379.
139. Nussenblatt R.B. Proctor Lecture. experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Investigative Ophthalmology & Visual Science 1991, 32:3131-3141.
140. O'Donnell W.T., Warren S.T. A decade of molecular studies of Fragile X Syndrome. Annual Review of Neuroscience 2002, 25:315-338.
141. Ogawa K., Chen F., Kim Y.-J., Chen Y. Transcriptional regulation of tristetraprolin by transforming growth factor-beta1 in human T cells. Journal of Biological Chemistry 2003, 278:30373-30381.
142. Oguma K., Oshima H., Aoki M., Uchio R., Naka K., Nakamura S., Hirao A., Saya H., Taketo M.M., Oshima M. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. The EMBO Journal 2008, 27:1671-1681.
143. Old L.J. Tumor necrosis factor (TNF). Science 1985, 230:630-632.
144. Olleros M.L., Guler R., Corazza N., Vesin D., Eugster H.-P., Marchal G., Chavarot P., Mueller C., Garcia I. Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-alpha. The Journal of Immunology 2002, 168:3394-3401.
145. Olleros M.L., Guler R., Vesin D., Parapanov R., Marchal G., Martinez-Soria E., Corazza N., Pache J.-C., Mueller C., Garcia I. Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-Guerin and Mycobacterium tuberculosis infections. American Journal of Pathology 2005, 166:1109-1120.
146. Olleros Maria L., Vesin D., Lambou Agathe F., Janssens J.P., Ryffel B., Rose S., Fremond C., Quesniaux Valerie F., Szymkowski David E., Garcia I. Dominant-negative tumor necrosis factor protects from Mycobacterium bovis bacillus Calmette-Guerin (BCG) and endotoxin-induced Liver injury without compromising host immunity to BCG and ycobacterium tuberculosis. The Journal of Infectious Diseases 2009, 199:1053-1063.
147. Ozdamar Y., Berker N., Bahar G., Soykan E., Bicer T., Ozkan S., Karakaya J. Inflammatory mediators and posterior segment involvement in ocular Behcet disease. European Journal of Ophthalmology 2009, 19:998-1003.
148. Pakala S.V., Chivetta M., Kelly C.B., Katz J.D. Autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor-alpha. The Journal of Experimental Medicine 1999, 189:1053-1062.
149. Pasparakis M., Alexopoulou L., Episkopou V., Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. The Journal of Experimental Medicine 1996, 184:1397-1411.
150. Pasparakis M., Alexopoulou L., Grell M., Pfizenmaier K., Bluethmann H., Kollias G. Peyers patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kD receptor. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:6319-6323.
151. Phillips K., Kedersha N., Shen L., Blackshear P.J., Anderson P. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor α, cyclooxygenase 2, and inflammatory arthritis. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2011-2016.
152. Piecyk M., Wax S., Beck A.R.P., Kedersha N., Gupta M., Maritim B., Chen S., Gueydan C., Kruys V., Streuli M., Anderson P. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. The EMBO Journal 2000, 19:4154-4163.
153. Pukrop T., Klemm F., Hagemann T., Gradl D., Schulz M., Siemes S., Trumper L., Binder C. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:5454-5459.
154. Ransohoff R.M., Tani M. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inf lammation?. Trends in Neurosciences 1998, 21:154-159.
155. Raveney, B.J.E., Copland, D.A., Claudia, J.C., Dick, A.D., and Nicholson, L.B. TNFR1 signalling is a critical checkpoint for developing macrophages that control of T-cell proliferation. Immunology, in press.
156. Raveney B.J.E., Copland D.A., Dick A.D., Nicholson L.B. TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis. The Journal of Immunology 2009, 183:2321-2329.
157. Riminton D.S., Korner H., Strickland D.H., Lemckert F.A., Pollard J.D., Sedgwick J.D. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-alpha deficient, mice. The Journal of Experimental Medicine 1998, 187:1517-1528.
158. Robertson M., Liversidge J., Forrester J.V., Dick A.D. Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis. Investigative Ophthalmology & Visual Science 2003, 44:3034-3041.
159. Robertson M.J., Erwig L.P., Liversidge J., Forrester J.V., Rees A.J., Dick A.D. Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis. Investigative Ophthalmology & Visual Science 2002, 43:2250-2257.
160. Rosenbaum J.T., Howes E.L., Rubin R.M., Samples J.R. Ocular inflammatory effects of intravitreally-injected tumor necrosis factor. American Journal of Pathology 1988, 133:47-53.
161. Rossol-Voth R., Rossol S., Schutt K.H., Corridori S., de Cian W., Falke D. In vivo protective effect of tumour necrosis factor-alpha against experimental infection with herpes simplex virus type 1. Journal of General Virology 1991, 72:143-147.
162. Rossol M., Meusch U., Pierer M., Kaltenhauser S., Hantzschel H., Hauschildt S., Wagner U. Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells. The Journal of Immunology 2007, 179:4239-4248.
163. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. The Journal of Experimental Medicine 1990, 172:1193-1200.
164. Ruuls S.R., Hoek R.M., Ngo V.N., McNeil T., Lucian L.A., Janatpour M.J., Körner H., Scheerens H., Hessel E.M., Cyster J.G., et al. Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 2001, 15:533-543.
165. Sakai K., Kitagawa Y., Hirose G. Binding of neuronal ELAV-like proteins to the uridine-rich sequence in the 3′-untranslated region of tumor necrosis factor-[alpha] messenger RNA. FEBS Letters 1999, 446:157-162.
166. Sandler H., Stoecklin G. Control of mRNA decay by phosphorylation of tristetraprolin. Biochemical Society Transactions 2008, 036:491-496.
167. Santos Lacomba M., Marcos Martin C., Gallardo Galera J.M., Gomez Vidal M.A., Collantes Estevez E., Ramerez Chamond R., Omar M.M. Aqueous humor and serum tumor necrosis factor-apha in clinical uveitis. Ophthalmic Research 2001, 33:251-255.
168. Sauer I., Schaljo B., Vogl C., Gattermeier I., Kolbe T., Muller M., Blackshear P.J., Kovarik P. Interferons limit inflammatory responses by induction of tristetraprolin. Blood 2006, 107:4790-4797.
169. Schaljo B., Kratochvill F., Gratz N., Sadzak I., Sauer I., Hammer M., Vogl C., Strobl B., Muller M., Blackshear P.J., et al. Tristetraprolin is required for full anti-inflammatory response of murine macrophages to IL-10. The Journal of Immunology 2009, 183:1197-1206.
170. Schewitz-Bowers L.P., Lee R.W.J., Dick A.D. Immune mechanisms of intraocular inflammation. Expert Review of Ophthalmology 2010, 5:43-58.
171. Sedgwick J.D., Riminton D.S., Cyster J.G., Körner H. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunology Today 2000, 21:110-113.
172. Sen M., Lauterbach K., El-Gabalawy H., Firestein G.S., Corr M., Carson D.A. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:2791-2796.
173. Sharma S.M., Nestel A.R., Lee R.W.J., Dick A.D. Clinical review: anti-TNF-alpha therapies in uveitis: perspective on 5 years of clinical experience. Ocular Immunology and Inflammation 2009, 17:403-414.
174. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46:659-667.
175. Siomi M.C., Siomi H., Sauer W.H., Srinivasan S., Nussbaum R.L., Dreyfuss G. FXR1, an autosomal homolog of the fragile X mental retardation gene. The EMBO Journal 1995, 14:2401-2408.
176. Stoecklin G., Lu M., Rattenbacher B., Moroni C. A constitutive decay element promotes tumor necrosis factor alpha mRNA degradation via an AU-rich element-independent pathway. Molecular and Cellular Biology 2003, 23:3506-3515.
177. Stoecklin G., Stubbs T., Kedersha N., Wax S., Rigby W.F.C., Blackwell T.K., Anderson P. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. The EMBO Journal 2004, 23:1313-1324.
178. Sugita S., Takase H., Taguchi C., Mochizuki M. The role of soluble TNF receptors for TNF-alpha in uveitis. Investigative Ophthalmology & Visual Science 2007, 48:3246-3252.
179. Sun L., Stoecklin G., Van Way S., Hinkovska-Galcheva V., Guo R.-F., Anderson P., Shanley T.P. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-α mRNA. Journal of Biological Chemistry 2007, 282:3766-3777.
180. Suswam E.A., Li Y.Y., Mahtani H., King P.H. Novel DNA-binding properties of the RNA-binding protein TIAR. Nucleic Acids Research 2005, 33:4507-4518.
181. Suzuki K., Nakajima H., Ikeda K., Maezawa Y., Suto A., Takatori H., Saito Y., Iwamoto I. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells. The Journal of Experimental Medicine 2003, 198:1717-1727.
182. Szabo A., Dalmau J., Manley G., Rosenfeld M., Wong E., Henson J., Posner J.B., Furneaux H.M. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and sex-lethal. Cell 1981, 67:325-333.
183. Taganov K.D., Boldin M.P., Chang K.-J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:12481-12486.
184. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., Schenkman D.I., Gilkeson G.S., Broxmeyer H.E., Haynes B.F., Blackshear P.J. A Pathogenetic role for TNF-alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 1996, 4:445-454.
185. Tessier P.A., Naccache P.H., Clark-Lewis I., Gladue R.P., Neote K.S., McColl S.R. Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. The Journal of Immunology 1997, 159:3595-3602.
186. Thabet M., Huizinga T. Apratastat, a novel TACE/MMP inhibitor for rheumatoid arthritis. Current Opinion in Investigational Drugs 2006, 7:1014-1019.
187. Theodossiadis P.G., Liarakos V.S., Sfikakis P.P., Vergados I.A., Theodossiadis G.P. Intravitreal Administration of the anti-tumor necrosis factor agent infliximab for Neovascular age-related macular degeneration. American Journal of Ophthalmology 2009, 147:825-830. e821.
188. Tian Q., Streuli M., Saito H., Schlossman S.F., Anderson P. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 1991, 67:629-639.
189. Tili E., Michaille J.-J., Cimino A., Costinean S., Dumitru C.D., Adair B., Fabbri M., Alder H., Liu C.G., Calin G.A., Croce C.M. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. The Journal of Immunology 2007, 179:5082-5089.
190. Vassalli P. The pathophysiology of tumor necrosis factors. Annual Review of Immunology 1992, 10:411-452.
191. Vasudevan S., Steitz J.A. AU-rich-element-mediated upregulation of translation by FXR1 and argonaute 2. Cell 2007, 128:1105-1118.
192. von Boehmer H. Lymphotoxins: from cytotoxicity to lymphoid organogenesis. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:8926-8927.
193. Wang W., Yang X., Kawai T., de Silanes I.L., Mazan-Mamczarz K., Chen P., Chook Y.M., Quensel C., Kohler M., Gorospe M. AMP-activated protein kinase-regulated phosphorylation and acetylation of importin alpha 1. Journal of Biological Chemistry 2004, 279:48376-48388.
194. Weil D., Brosset S., Dautry F. RNA processing is a limiting step for murine tumor necrosis factor beta expression in response to interleukin-2. Molecular and Cellular Biology 1990, 10:5865-5875.
195. Winkler B.S., Boulton M.E., Gottsch J.D., Sternberg P. Oxdative damage and age-related macular degeneration. Molecular Vision 1999, 5:32.
196. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C.-Y.A., Shyu A.-B., Muller M., Gaestel M., Resch K., Holtmann H. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. The EMBO Journal 1999, 18:4969-4980.
197. Xu H., Chen M., Forrester J.V. Para-inflammation in the Aging Retina 2009, vol. 28. Oxford, ROYAUME-UNI: Elsevier.
198. Xu K., Bogert B.A., Li W., Su K., Lee A., Gao F.-B. The fragile X-related gene affects the crawling behavior of Drosophila larvae by regulating the mRNA level of the DEG/ENaC protein Pickpocket1. Current Biology: CB 2004, 14:1025-1034.
199. Yamasaki S., Stoecklin G., Kedersha N., Simarro M., Anderson P. T-cell intracellular antigen-1 (TIA-1)-induced translational silencing promotes the decay of selected mRNAs. Journal of Biological Chemistry 2007, 282:30070-30077.
200. Yang E., van Nimwegen E., Zavolan M., Rajewsky N., Schroeder M., Magnasco M., Darnell J.E. Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes. Genome Research 2003, 13:1863-1872.
201. Yokoi H., Kato K., Kezuka T., Sakai J., Usui M., Yagita H., Okumura K. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12. European Journal of Immunology 1997, 27:641-646.
202. Yoshimura T., Sonoda K.-H., Miyazaki Y., Iwakura Y., Ishibashi T., Yoshimura A., Yoshida H. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. International Immunology 2008, 20:209-214.
203. Zalevsky J., Secher T., Ezhevsky S.A., Janot L., Steed P.M., O'Brien C., Eivazi A., Kung J., Nguyen D.-H.T., Doberstein S.K., et al. Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection. The Journal of Immunology 2007, 179:1872-1883.
204. Zhou T., Hu Y., Chen Y., Zhou K., Zhang B., Gao G., Ma J.-X. The pathogenic role of the canonical Wnt pathway in age-related macular degeneration. Investigative Ophthalmology & Visual Science 2009, iovs.09-4278.
205. Zorena K., Mysliwska J., Mysliwiec M., Balcerska A., Hak L., Lipowski P., Raczynska K. Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children. Mediators of Inflammation 2007, 2007:92196-92201.
206. Zuckerman S.H., Evans G.F., Snyder Y.M., Roeder W.D. Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression. The Journal of Immunology 1989, 143:1223-1227.